allogeneic UC-MSCs
/ Asia Cell Therap
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
August 09, 2023
Safety and Tolerance of Umbilical Cord Mesenchymal Stem Cells in Patients With Acute Respiratory Distress Syndrome
(clinicaltrials.gov)
- P1 | N=9 | Not yet recruiting | Sponsor: Asia Cell Therapeutics (Shanghai) Co., Ltd.
New P1 trial • Acute Respiratory Distress Syndrome • Pulmonary Disease • Respiratory Diseases
July 27, 2023
Safety and Tolerance of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Ankylosing Spondylitis
(clinicaltrials.gov)
- P1 | N=9 | Not yet recruiting | Sponsor: Asia Cell Therapeutics (Shanghai) Co., Ltd.
New P1 trial • Ankylosing Spondylitis • Immunology • Inflammatory Arthritis • Rheumatology • Seronegative Spondyloarthropathies • CRP
July 17, 2023
Safety of Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in Patients With Decompensated Hepatitis B Cirrhosis
(clinicaltrials.gov)
- P1/2 | N=18 | Not yet recruiting | Sponsor: Asia Cell Therapeutics (Shanghai) Co., Ltd.
New P1/2 trial • Fibrosis • Gastroenterology • Hepatitis B • Hepatology • Immunology • Infectious Disease • Inflammation • Liver Cirrhosis • AFP • CA 19-9 • CD4 • CD8 • CEACAM5
1 to 3
Of
3
Go to page
1